Invesco Ltd. Ligand Pharmaceuticals Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 188,728 shares of LGND stock, worth $21.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

188,728

Previous 172,811 9.21%

Holding current value

$21.1 Million

Previous $14.6 Million 29.83%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$82.7 - $110.11 $1.32 Million - $1.75 Million	15,917 Added 9.21%	188,728 $18.9 Million
Q2 2024 Aug 13, 2024	SELL	$68.53 - $87.91 $2.9 Million - $3.72 Million	-42,284 Reduced 19.66%	172,811 $14.6 Million
Q1 2024 May 14, 2024	BUY	$68.64 - $89.2 $13,316 - $17,304	194 Added 0.09%	215,095 $15.7 Million
Q4 2023 Feb 12, 2024	SELL	$49.57 - $72.63 $192,629 - $282,240	-3,886 Reduced 1.78%	214,901 $15.3 Million
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $188,116 - $232,253	-3,196 Reduced 1.44%	218,787 $13.1 Million
Q2 2023 Aug 11, 2023	SELL	$69.53 - $79.33 $286,463 - $326,839	-4,120 Reduced 1.82%	221,983 $16 Million
Q1 2023 May 12, 2023	SELL	$65.67 - $77.08 $51,419 - $60,353	-783 Reduced 0.35%	226,103 $16.6 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $2.21 Million - $3.46 Million	35,815 Added 18.74%	226,886 $15.2 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $279 - $3.01 Million	-27,963 Reduced 12.77%	191,071 $16.5 Million
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $1.82 Million - $2.86 Million	24,468 Added 12.58%	219,034 $19.5 Million
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $1.37 Million - $2.19 Million	-14,446 Reduced 6.91%	194,566 $21.9 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $7.96 Million - $10.3 Million	-62,359 Reduced 22.98%	209,012 $32.3 Million
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $3.45 Million - $4.88 Million	33,684 Added 14.17%	271,371 $37.8 Million
Q2 2021 Aug 17, 2021	BUY	$113.03 - $155.64 $4.17 Million - $5.75 Million	36,919 Added 18.39%	237,687 $31.2 Million
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $691,863 - $1.5 Million	6,952 Added 3.59%	200,768 $30.6 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $743,798 - $979,265	9,234 Added 5.0%	193,816 $19.3 Million
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $2.56 Million - $3.62 Million	28,541 Added 18.29%	184,582 $17.6 Million
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $392,268 - $710,369	5,745 Added 3.82%	156,041 $17.5 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $3.08 Million - $5.25 Million	-48,660 Reduced 24.46%	150,296 $10.9 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $16.4 Million - $19.2 Million	169,023 Added 564.67%	198,956 $20.7 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $29.1 Million - $40.5 Million	-337,080 Reduced 91.84%	29,933 $2.98 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $34.9 Million - $42.1 Million	325,273 Added 779.28%	367,013 $41.9 Million
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $9.05 Million - $12.2 Million	-85,432 Reduced 67.18%	41,740 $5.25 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $16.3 Million - $34.6 Million	127,172 New	127,172 $17.3 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account